Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a EV/Sales of 9.8×. Over the past ten years it has ranged from 3.9× (January 2016) to 20.0× (August 2021); the current reading is higher than 46% of that period. That is above the Diagnostics & Research industry median of 5.5× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 12.7× 43.85%
FY2024 8.8× (29.30%)
FY2023 12.5× 21.56%
FY2022 10.3× (41.83%)
FY2021 17.7× 10.73%
FY2020 16.0× 64.11%
FY2019 9.7× 29.33%
FY2018 7.5× 5.83%
FY2017 7.1× 17.26%
FY2016 6.1× 38.47%

Quarterly newest first

Period EV/Sales Change
Jun 2026 9.2× (9.27%)
Mar 2026 10.1× (20.34%)
Dec 2025 12.7× 2.84%
Sep 2025 12.4× 14.71%
42 more quarters

Against its own ten years

Low 3.9× High 20.0×
Ten-year median 10.0×
Current reading's percentile 41

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. compare 3.4×
A Agilent Technologies, Inc. compare 6.9×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. 9.8×
WAT Waters Corporation compare 10.2×
NTRA Natera, Inc. compare 20.5×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on IDXX